Your Academy is grateful for the advocacy of our many members who engaged in the comment process via our letter-writing campaign on these LCDs. We’d like to highlight several members who helped draft our Academy comments and worked collaboratively with leadership at the MACs to review evidence and discuss the needs of the spasticity patient population. Thank you to John Baratta, MD, MBA, FAAPMR; Zachary Bohart, MD, MS, FAAPMR; Kimberly Heckert, MD, FAAPMR; Christina Kwasnica, MD, FAAPMR; and Lauren Shapiro, MD, MPH, FAAPMR for more than a year of advocacy!
Spasticity remains an ongoing priority for AAPM&R in many areas. We invite members to join the conversation in the Spasticity Community. You can join any community by updating your member profile
here. You may also learn about updates
here and watch for upcoming information about spasticity-related Expert Conversations in PM&R Practice.
“Without the direct educational and advocacy efforts of AAPM&R, these policies to decrease the dose of botulinum toxins we can give our patients surely would have passed. The Academy deserves all of our thanks for mounting such a concerted and well-planned effort, and they’ve gained an involved, active member for life.”
—Zachary W. Bohart, MD, MS, FAAPMR
Final policies, which take effect on February 22, 2026, are linked below.